Effect of Cardiac Resynchronization Therapy on Pulmonary Function in Patients With Heart Failure

被引:10
|
作者
Cundrle, Ivan, Jr. [1 ,2 ]
Johnson, Bruce D. [2 ]
Somers, Virend K. [2 ]
Scott, Christopher G. [3 ]
Rea, Robert F. [2 ]
Olson, Lyle J. [2 ]
机构
[1] St Annas Univ Hosp, Dept Anesthesiol & Intens Care, Int Clin Res Ctr, Brno, Czech Republic
[2] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2013年 / 112卷 / 06期
关键词
INTERSTITIAL LUNG-DISEASE; AIRWAY-OBSTRUCTION; SLEEP-APNEA; HYPERTENSION; EXERCISE; IMPROVEMENT; MANAGEMENT; DIAGNOSIS; CAPACITY; PATTERN;
D O I
10.1016/j.amjcard.2013.05.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary congestion due to heart failure causes abnormal lung function. Cardiac resynchronization therapy (CRT) is a proven effective treatment for heart failure. The aim of this study was to test the hypothesis that CRT promotes increased lung volumes, bronchial conductance, and gas diffusion. Forty-four consecutive patients with heart failure were prospectively investigated before and after CRT. Spirometry, gas diffusion (diffusing capacity for carbon monoxide), cardiopulmonary exercise testing, New York Heart Association class, brain natriuretic peptide, the left ventricular ejection fraction, left atrial volume, and right ventricular systolic pressure were assessed before and 4 to 6 months after CRT. Pre- and post-CRT measures were compared using either paired Student's t tests or Wilcoxon's matched-pair test; p values <0.05 were considered significant. Improved New York Heart Association class, left ventricular ejection fraction, left atrial volume, right ventricular systolic pressure, and brain natriuretic peptide were observed after CRT (p <0.05 for all). Spirometry after CRT demonstrated increased percentage predicted total lung capacity (90, 17% vs 96 +/- 15%, p <0.01) and percentage predicted forced vital capacity (80 +/- 19% vs 90 +/- 19%, p <0.01). Increased percentage predicted total lung capacity was significantly correlated with increased peak exercise end-tidal carbon dioxide (r = 0.43, p = 0.05). Increased percentage predicted forced vital capacity was significantly correlated with decreased right ventricular systolic pressure (r = 0.30, p = 0.05), body mass index (r = 0.35, p = 0.02) and creatinine (r = 0.49, p = 0.02), consistent with an association of improved bronchial conductance and decreased congestion. Diffusing capacity for carbon monoxide did not significantly change. In conclusion, increased lung volumes and bronchial conductance due to decreased pulmonary congestion and increased intrathoracic space contribute to an improved breathing pattern and decreased hyperventilation after CRT. Persistent alveolar-capillary membrane remodeling may account for unchanged diffusing capacity for carbon monoxide. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:838 / 842
页数:5
相关论文
共 50 条
  • [21] Cardiac resynchronization therapy for heart failure
    Abraham, WT
    Hayes, DL
    CIRCULATION, 2003, 108 (21) : 2596 - 2603
  • [22] Cardiac resynchronization therapy for heart failure
    Ross H.M.
    Kocovic D.Z.
    Current Treatment Options in Cardiovascular Medicine, 2004, 6 (5) : 365 - 370
  • [23] Cardiac resynchronization therapy for heart failure
    Michael R. Gold
    Current Cardiology Reports, 2006, 8 (5) : 314 - 315
  • [24] Cardiac resynchronization therapy in heart failure
    Koniari, I.
    Apostolakis, E.
    ARCHIVES OF HELLENIC MEDICINE, 2008, 25 (05): : 595 - 601
  • [25] IMPROVEMENT OF RENAL FUNCTION AFTER CARDIAC RESYNCHRONIZATION THERAPY IMPLANTATION IN PATIENTS WITH HEART FAILURE
    Piccone Saponara, Luis Guillermo
    Uribe Heredia, Nancy Giovanna
    Vozmediano Poyatos, Maria Carmen
    Carreno Parrilla, Agustin
    Arroyo Espliguero, Ramon
    Novo Garcia, Enrique
    Moreno Reviriego, Sara
    Jimenez Martinez, Maria Eulalia
    Anaya Fernandez, Sara
    Rivera Hernandez, Francisco
    Balaguer Recena, Javier
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [26] Prognostic value of liver function tests in heart failure patients with cardiac resynchronization therapy
    Hosoda, J.
    Ishikawa, T.
    Umemura, S.
    Andoh, K.
    Nobuyoshi, M.
    Fujii, S.
    Shizuta, S.
    Kimura, T.
    Isshiki, T.
    EUROPEAN HEART JOURNAL, 2015, 36 : 57 - 57
  • [27] Cardiac resynchronization therapy improves pulmonary hypertension in congestive heart failure
    Cha, YM
    Rea, RF
    Shen, WK
    Asirvatham, SJ
    Turnbull, DM
    Hyberger, LK
    Hayes, DL
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 116A - 116A
  • [28] Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients
    Butter, C
    Auricchio, A
    Stellbrink, C
    Fleck, E
    Ding, J
    Yu, YH
    Huvelle, E
    Spinelli, J
    CIRCULATION, 2001, 104 (25) : 3026 - 3029
  • [29] Predictive Value of Pulmonary Capillary Wedge Pressure for Heart Failure Hospitalization in Heart Failure Patients with Cardiac Resynchronization Therapy
    Suzuki, Atsushi
    Shiga, Tsuyoshi
    Yoshida, Kentaro
    Serizawa, Naoki
    Kato, Ken
    Ejima, Koichiro
    Suzuki, Tsuyoshi
    Manaka, Tetsuyuki
    Shoda, Morio
    Hagiwara, Nobuhisa
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : S187 - S187
  • [30] Optimizing therapy for heart failure patients: Cardiac resynchronization and defibrillator therapy
    Jensen, Scot B.
    Galvin, Catherine A.
    Thompson, Brenda
    Rasmussen, Mary Jane
    JOURNAL OF CARDIOVASCULAR NURSING, 2007, 22 (02) : 118 - 124